Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

6 days ago · Tempus plans to report its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. About Tempus Tempus is a technology company …

Jan 11, 2026 · Tempus is in the process of completing its customary year-end close and review procedures for the quarter and year ended December 31, 2025, and there can be no assurance that …

For clinicians associated with advanced research initiatives, Tempus provides next-generation genomic profiling, biological organoid modeling, image/pattern AI recognition, and a range of clinical trial and …

Tempus is a healthcare technology company advancing the use of AI in precision oncology. By integrating comprehensive molecular and clinical data, we deliver actionable insights that help …

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier academic medical centers, today announced a multi-year strategic collaboration …

Jan 11, 2026 · Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

We’re building innovative tech solutions oriented around clinical care and research products—and the virtuous cycle between them. A desktop and mobile platform for ordering, managing, and receiving …

Jan 6, 2026 · CHICAGO -- (BUSINESS WIRE)--Jan. 12, 2026-- Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health , one of the nation’s premier academic medical …